SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

COSCIENS BIOPHARMA INC. REPORTS Q3 2026 RESULTS AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERING

COSCIENS BIOPHARMA INC. REPORTS Q3 2026 RESULTS AND PROVIDES UPDATE ON CONVERTIBLE DEBENTURE OFFERIN

Related stories